GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Misonix Inc (NAS:MSON) » Definitions » Shiller PE Ratio

Misonix (Misonix) Shiller PE Ratio : (As of Apr. 26, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Misonix Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Misonix Shiller PE Ratio Historical Data

The historical data trend for Misonix's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Misonix Shiller PE Ratio Chart

Misonix Annual Data
Trend Jun12 Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Misonix Quarterly Data
Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Misonix's Shiller PE Ratio

For the Medical Devices subindustry, Misonix's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Misonix's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Misonix's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Misonix's Shiller PE Ratio falls into.



Misonix Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Misonix's E10 for the quarter that ended in Jun. 2021 is calculated as:

For example, Misonix's adjusted earnings per share data for the three months ended in Jun. 2021 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jun. 2021 (Change)*Current CPI (Jun. 2021)
=-0.26/114.6314*114.6314
=-0.260

Current CPI (Jun. 2021) = 114.6314.

Misonix Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201109 -0.130 95.727 -0.156
201112 0.150 95.213 0.181
201203 -0.030 96.783 -0.036
201206 0.060 96.819 0.071
201209 0.010 97.633 0.012
201212 -0.090 96.871 -0.107
201303 -0.080 98.209 -0.093
201306 -0.220 98.518 -0.256
201309 -0.120 98.790 -0.139
201312 0.060 98.326 0.070
201403 0.050 99.695 0.057
201406 0.180 100.560 0.205
201409 0.050 100.428 0.057
201412 0.110 99.070 0.127
201503 0.050 99.621 0.058
201506 0.480 100.684 0.546
201509 -0.030 100.392 -0.034
201512 0.020 99.792 0.023
201603 -0.090 100.470 -0.103
201606 -0.060 101.688 -0.068
201609 -0.070 101.861 -0.079
201612 -0.070 101.863 -0.079
201703 -0.020 102.862 -0.022
201706 -0.040 103.349 -0.044
201709 -0.140 104.136 -0.154
201712 -0.760 104.011 -0.838
201803 0.230 105.290 0.250
201806 -0.200 106.317 -0.216
201809 -0.290 106.507 -0.312
201812 -0.090 105.998 -0.097
201903 -0.170 107.251 -0.182
201906 -0.250 108.070 -0.265
201909 0.170 108.329 0.180
201912 -0.330 108.420 -0.349
202003 -0.340 108.902 -0.358
202006 -0.500 108.767 -0.527
202009 -0.290 109.815 -0.303
202012 -0.070 109.897 -0.073
202103 -0.220 111.754 -0.226
202106 -0.260 114.631 -0.260

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Misonix  (NAS:MSON) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Misonix Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Misonix's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Misonix (Misonix) Business Description

Traded in Other Exchanges
N/A
Address
1938 New Highway, Farmingdale, NY, USA, 11735
Misonix Inc is a medical devices company. It designs, manufactures, markets, and sells invasive surgical ultrasonic medical devices. The company's products enhance clinical outcomes and provide value to the overall healthcare system. It has developed products such as BoneScalpel, NeXus, Sequel, SonaStar, SonicOne, Theragenesis, TheraSkin, and Therion. These products are used for precise bone sculpting, removal of soft and hard tumors, tissue debridement, primarily in the areas of neurosurgery, orthopedic surgery, plastic surgery, wound care, and maxillo-facial surgery. The company generates revenue from various regions that include the United States, the United Kingdom, the European Economic Area, Asia and the Asia Pacific, and South America.
Executives
Paul A Laviolette director ONE BOSTON PLACE, 201 WASHINGTON STREET, SUITE 3900, BOSTON MA 02108
Sharon W Klugewicz officer: Chief Operating Officer 3661 HORSEBLOCK ROAD, MEDFORD NY 11763
Thomas M Patton director C/O OSTEOTCH INC., 51 JAMES WAY, EATONTOWN NJ 07724
Joseph P Dwyer officer: Chief Financial Officer 3 CORDWOOD COURT, E. NORTHPORT NY 11731
Gwendolyn A Watanabe director C/O SARATOGA VENTURES, 210 ALMENDRA AVENUE, LOS GATOS CA 95030
Linwood A. Staub officer: Sr. VP Wound 8023 VANTAGE DRIVE SAN ANTONIO TX 78230
Stavros G. Vizirgianakis director, officer: CEO 1/16-18 TENNYSON ST., WILLIAMSTOWN NORTH, VICTORIA CA 3016
Robert S Ludecker officer: SVP Sales - Surgical 4 WILDBRIAR COURT MOUNT SINAI NY 11766
Allan Richard Staley officer: President C/O SOLSYS MEDICAL, LLC 600 THIMBLE SHOALS BLVD., SUITE 200 NEWPORT NEWS VA 23606
Michael Koby director C/O 1315 CAPITAL 2929 WALNUT STREET, SUITE 1240 PHILADELPHIA PA 19104
1315 Capital Management, Llc 10 percent owner 2929 WALNUT STREET SUITE 1240 PHILADELPHIA PA 19104
Sv Life Sciences Fund Vi (gp), L.p. 10 percent owner ONE BOSTON PLACE, 201 WASHINGTON STREET, SUITE 3900, BOSTON MA 02108
Svlsf Vi, Llc 10 percent owner ONE BOSTON PLACE, 201 WASHINGTON STREET, SUITE 3900, BOSTON MA 02108
Sv Life Sciences Fund Vi Strategic Partners, L.p. 10 percent owner C/O SV LIFE SCIENCES ADVISERS, LLC, ONE BOSTON PLACE, SUITE 3900, BOSTON MA 02108
1315 Capital, L.p. 10 percent owner 3020 MARKET STREET, SUITE 104 PHILADELPHIA PA 19104

Misonix (Misonix) Headlines